
Michigan site adds 110,000 square feet to its production footprint as company aims to meet additional demand

Michigan site adds 110,000 square feet to its production footprint as company aims to meet additional demand

Acquisition boosts C> portfolio by 622,000 square feet, as CDMO eyes global expansion

CDMO's North Carolina development adds over 3,700 square feet worth of manufacturing space, equipment

Among focal points, New Jersey location will support clinical research, pharmacovigilance

CDMO says BFS capacity can now reach over 2 billion units yearly

State and regional economic-development authorities compete fiercely for siting new pharma enterprises, and holding onto the ones they have. But pharma’s stupendous growth in investment is giving all regions a boost

Acquisition of US partner establishes Sanofi's plan to advance messenger RNA technology for vaccines, therapeutics

Baltimore facility production was stopped after FDA flagged millions of contaminated doses

German drugmaker also plans to set up manufacturing facilities in Africa

Deal for antibody developer expected to be largest ever for scientific instrument maker

In-house center eliminates the need for a contract manufacturer, company says

How pharma’s retooling of its promotional efforts in the post-pandemic era impacts sizing and targeting, two crucial foundational pieces to successful commercialization

Per agreement, facility will be producing over 100 million doses annually for use in African Union

Robotic filling and capping equipment to be installed in NIBRT’s global bioprocessing training and research center

Plans a multi-phase, $100 million expansion, adding biologics drug substance manufacturing capabilities

Deal allows CDMO to quickly expand its drug delivery technologies in the US

Will produce plasmid DNA-based therapies, mRNA vaccine materials

CDMO looks to strengthen its presence in Belgium, Sweden and the Netherlands

Biopharma company plans for facility to also serve as its new HQ

As customer base grows, packaging company decides to wrap global divisions under one name

Latest deal expands CDMO’s biologics expertise

New large-scale plant in Barcelona part of company's capacity-expansion pursuits to capitalize on biopharma's increased demand for lyophilization equipment

Outlining the business-vital areas pharma organizations should consider today in energy risk management, including the value of resiliency

Mission is to expand its collection of mRNA vaccines beyond the Covid-19 pandemic

Mourenx location will install new equipment, add hires in project as part of the France Relance recovery plan